JetBlue recently announced the winners for the fourth cycle of its BlueBud business mentoring program. Eat Your Coffee, Sustainable Snacks and 9 Miles East Farm will participate in an in-depth business mentorship program with JetBlue, learning what it takes to get their brands off the ground. BlueBud offers innovative and budding food and beverage brands a unique opportunity including access to JetBlue’s leaders and an inside look at the airline’s distinctive product development culture and award-winning onboard experience. The BlueBud program launched in 2015 and originally focused on up-and-coming environmentally and socially responsible food brands based in New York. JetBlue has expanded the program to include small businesses in the greater Boston area.
The Medtronic Foundation today announced 12 individuals from around the world as recipients of the 2018 Bakken Invitation. This Medtronic Foundation program recognizes and connects people who “live on, give on and dream on” through their advocacy, contributions to innovation and volunteerism after overcoming health challenges with the help of medical technology.
Four years ago, a disease that rarely made headlines — Ebola — raged in West Africa. There was no vaccine, treatment or cure. Though the initial response was slow, the international community ultimately mobilized resources, developed scientific innovations and promised to make sure a tragedy on the same scale would never happen again.
LIXIL, maker of pioneering water and housing products, on December 21 received the Deputy-Chief’s Award (from the Minister of Foreign Affairs) at the second Japan SDGs Awards, sponsored by the SDGs Promotion Headquarters comprising all cabinet ministers. The Japan SDGs Awards recognize exceptional efforts by companies and other organizations toward achieving the Sustainable Development Goals (SDGs) established by the United Nations. LIXIL has been conducting activities aimed at resolving the social and sanitation issues brought by a lack of toilet facilities through public-private partnerships and other initiatives to provide sanitary toilets to people around the world.
In 1992, as a young HIV/AIDS researcher in her native Netherlands, Hanneke Schuitemaker, Ph.D., now Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention B.V., was devoted to learning as much as she could about the disease—and saw her role as that of a researcher, rather than someone who closely interacted with people who were living with HIV.